0305 GMT - Raffles Medical Group stands to benefit from its exclusive contract with Changi Airport Group for on-arrival polymerase-chain-reaction (PCR) testing, UOB Kay Hian says. Singapore recently announced the opening of nine additional vaccinated travel lanes (VTLs), allowing quarantine-free travel to countries like the U.K. and the U.S., the brokerage notes. Management noted that VTL passengers leaving Singapore after their stay tend to return to Raffles Medical Group for pre-departure PCR testing, which provides some customer stickiness and additional PCR swab testing revenue. The brokerage raises the stock's target price to S$1.66 from S$1.43 and maintains a buy rating. Shares are 0.7% lower at S$1.52. (ronnie.harui@wsj.com)